4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318 | +15.6% | 25,000 | +56.2% | 0.15% | +16.7% |
| Q1 2023 | $275 | -66.5% | 16,000 | -56.8% | 0.13% | -68.2% |
| Q4 2022 | $822 | -99.8% | 37,000 | -27.5% | 0.40% | +85.9% |
| Q3 2022 | $410,000 | +91.6% | 51,000 | +66.6% | 0.21% | +104.8% |
| Q2 2022 | $214,000 | – | 30,614 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 377,777 | $15,659,000 | 5.43% |
| BVF INC/IL | 1,106,070 | $45,847,000 | 1.80% |
| Eagle Health Investments LP | 50,000 | $2,073,000 | 1.33% |
| Ally Bridge Group (NY) LLC | 150,000 | $6,218,000 | 1.07% |
| Casdin Capital, LLC | 780,555 | $32,354,000 | 0.96% |
| VIKING GLOBAL INVESTORS LP | 3,937,914 | $163,227,000 | 0.45% |
| Pinz Capital Management, LP | 19,900 | $825,000 | 0.38% |
| ArrowMark Colorado Holdings LLC | 1,063,744 | $44,092,000 | 0.34% |
| Perceptive Advisors | 600,256 | $24,881,000 | 0.27% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $829,000 | 0.23% |